KalVista Pharmaceuticals Statistics
Total Valuation
KALV has a market cap or net worth of $1.37 billion. The enterprise value is $1.35 billion.
Important Dates
The next estimated earnings date is Thursday, July 9, 2026, before market open.
| Earnings Date | Jul 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KALV has 51.22 million shares outstanding. The number of shares has increased by 12.33% in one year.
| Current Share Class | 51.22M |
| Shares Outstanding | 51.22M |
| Shares Change (YoY) | +12.33% |
| Shares Change (QoQ) | +2.42% |
| Owned by Insiders (%) | 2.17% |
| Owned by Institutions (%) | 96.05% |
| Float | 32.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.55 |
| Forward PS | 7.55 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.58
| Current Ratio | 5.58 |
| Quick Ratio | 5.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -59.81% |
| Weighted Average Cost of Capital (WACC) | 3.89% |
| Revenue Per Employee | $267,698 |
| Profits Per Employee | -$597,404 |
| Employee Count | 275 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.55M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.75% in the last 52 weeks. The beta is -0.12, so KALV's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | +96.75% |
| 50-Day Moving Average | 18.80 |
| 200-Day Moving Average | 15.12 |
| Relative Strength Index (RSI) | 75.31 |
| Average Volume (20 Days) | 5,553,556 |
Short Selling Information
The latest short interest is 19.65 million, so 38.35% of the outstanding shares have been sold short.
| Short Interest | 19.65M |
| Short Previous Month | 20.36M |
| Short % of Shares Out | 38.35% |
| Short % of Float | 60.58% |
| Short Ratio (days to cover) | 17.13 |
Income Statement
In the last 12 months, KALV had revenue of $73.62 million and -$164.29 million in losses. Loss per share was -$3.05.
| Revenue | 73.62M |
| Gross Profit | 18.94M |
| Operating Income | -166.27M |
| Pretax Income | -165.84M |
| Net Income | -164.29M |
| EBITDA | -164.82M |
| EBIT | -166.27M |
| Loss Per Share | -$3.05 |
Full Income StatementBalance Sheet
The company has $300.21 million in cash and $284.21 million in debt, with a net cash position of $16.01 million or $0.31 per share.
| Cash & Cash Equivalents | 300.21M |
| Total Debt | 284.21M |
| Net Cash | 16.01M |
| Net Cash Per Share | $0.31 |
| Equity (Book Value) | -2.71M |
| Book Value Per Share | -0.05 |
| Working Capital | 262.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$122.43 million and capital expenditures -$2.56 million, giving a free cash flow of -$124.99 million.
| Operating Cash Flow | -122.43M |
| Capital Expenditures | -2.56M |
| Depreciation & Amortization | 1.45M |
| Net Borrowing | 208.57M |
| Free Cash Flow | -124.99M |
| FCF Per Share | -$2.44 |
Full Cash Flow StatementMargins
Gross margin is 25.73%, with operating and profit margins of -225.86% and -223.16%.
| Gross Margin | 25.73% |
| Operating Margin | -225.86% |
| Pretax Margin | -225.27% |
| Profit Margin | -223.16% |
| EBITDA Margin | -223.88% |
| EBIT Margin | -225.86% |
| FCF Margin | n/a |
Dividends & Yields
KALV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.33% |
| Shareholder Yield | -12.33% |
| Earnings Yield | -12.03% |
| FCF Yield | -9.15% |
Analyst Forecast
The average price target for KALV is $30.80, which is 15.53% higher than the current price. The consensus rating is "Buy".
| Price Target | $30.80 |
| Price Target Difference | 15.53% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 33.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KALV has an Altman Z-Score of -2.56 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.56 |
| Piotroski F-Score | 1 |
